A conjugate comprising a first and second sequence, wherein the first sequence comprises at least part of the human low affinity Nerve Growth Factor receptor (LNGFR) or a polynucleotide coding for LNGFR, and the second sequence comprises at least part of a mutant HIV Nef or a polynucleotide coding for F12Nef.

 
Web www.patentalert.com

< Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes

> Method to induce neovascular formation and tissue regeneration

> L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
~ 00534